2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Editorial: Therapeutic potential of plant-derived metabolites in spinal or sciatic injury-induced neuropathic pain

      editorial

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: not found

          Cannabinoids as novel anti-inflammatory drugs.

          Cannabinoids are a group of compounds that mediate their effects through cannabinoid receptors. The discovery of Δ9-tetrahydrocannabinol (THC) as the major psychoactive principle in marijuana, as well as the identification of cannabinoid receptors and their endogenous ligands, has led to a significant growth in research aimed at understanding the physiological functions of cannabinoids. Cannabinoid receptors include CB1, which is predominantly expressed in the brain, and CB2, which is primarily found on the cells of the immune system. The fact that both CB1 and CB2 receptors have been found on immune cells suggests that cannabinoids play an important role in the regulation of the immune system. Recent studies demonstrated that administration of THC into mice triggered marked apoptosis in T cells and dendritic cells, resulting in immunosuppression. In addition, several studies showed that cannabinoids downregulate cytokine and chemokine production and, in some models, upregulate T-regulatory cells (Tregs) as a mechanism to suppress inflammatory responses. The endocannabinoid system is also involved in immunoregulation. For example, administration of endocannabinoids or use of inhibitors of enzymes that break down the endocannabinoids, led to immunosuppression and recovery from immune-mediated injury to organs such as the liver. Manipulation of endocannabinoids and/or use of exogenous cannabinoids in vivo can constitute a potent treatment modality against inflammatory disorders. This review will focus on the potential use of cannabinoids as a new class of anti-inflammatory agents against a number of inflammatory and autoimmune diseases that are primarily triggered by activated T cells or other cellular immune components.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine

            Quercetin is a flavonoid compound widely present in plants and exhibits a variety of biological activities. Research on quercetin has shown its potential for medical application. In this research, we elucidate its antioxidant mechanism and the broad-spectrum antibacterial and antiparasite properties; summarise its potential application in antioncology and cardiovascular protection and anti-immunosuppression treatment; and demonstrate its ability to alleviate the toxicity of mycotoxins. This research is expected to offer some insights and inspirations for the further study of quercetin, its properties, and the scientific basis for its better application in clinical practice.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Neuroprotective effects of resveratrol in Alzheimer disease pathology

              Alzheimer’s disease is a chronic neurodegenerative disorder characterized by a progressive loss of cognitive and behavioral abilities. Extracellular senile plaques and intracellular neurofibrillary tangles are hallmarks of AD. Researchers aim to analyze the molecular mechanisms underlying AD pathogenesis; however, the therapeutic options available to treat this disease are inadequate. In the past few years, several studies have reported interesting insights about the neuroprotective properties of the polyphenolic compound resveratrol (3, 5, 4′-trihydroxy-trans-stilbene) when used with in vitro and in vivo models of AD. The aim of this review is to focus on the neuroprotective and antioxidant effects of resveratrol on AD and its multiple potential mechanisms of action. In addition, because the naturally occurring forms of resveratrol have a very limited half-life in plasma, a description of potential analogs aimed at increasing the bioavailability in plasma is also discussed.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Pharmacol
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                17 July 2023
                2023
                : 14
                : 1251613
                Affiliations
                [1] 1 Department of Molecular Science and Technology , Ajou University , Suwon, Republic of Korea
                [2] 2 Riphah Institute of Pharmaceutical Sciences , Riphah International University , Islamabad, Pakistan
                Author notes

                Edited by: Javier Echeverria, University of Santiago, Chile

                Reviewed by: Luciana Scotti, Federal University of Paraíba, Brazil

                *Correspondence: Abdul Waheed Khan, waheedmarwat31@ 123456gmail.com ; Muhammad Faheem, fahimafridi345@ 123456gmail.com
                Article
                1251613
                10.3389/fphar.2023.1251613
                10390056
                c2f961f8-cbc2-4016-923b-71d0ce41c459
                Copyright © 2023 Khan, Shah, Nadir, Taufique and Faheem.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 02 July 2023
                : 10 July 2023
                Categories
                Pharmacology
                Editorial
                Custom metadata
                Ethnopharmacology

                Pharmacology & Pharmaceutical medicine
                cci,neuropathy,natural compounds,fiestin,quercitin
                Pharmacology & Pharmaceutical medicine
                cci, neuropathy, natural compounds, fiestin, quercitin

                Comments

                Comment on this article